期刊
CANCER DISCOVERY
卷 11, 期 6, 页码 1330-1335出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-21-0210
关键词
-
类别
资金
- ESMO-CoCare
- CCC19
Cancer patients have been significantly impacted by the COVID-19 pandemic, leading to changes in treatment decisions and disruptions in care. It is crucial for oncologists to make appropriate therapeutic choices based on clear recommendations to prevent a surge in cancer-related deaths in the coming months.
Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据